1-3 of 3
Sherry Pierce, RN, BSN, BA
Close
Sort by
Journal Articles

Long-Term Follow-Up Results of the Combination of Topotecan and Cytarabine and Other Intensive Chemotherapy Regimens in Myelodysplastic Syndrome.

Elias Jabbour, MD, Hagop Kantarjian, MD, Miloslav Beran, MD, PhD, DVM, Jorge Cortes, MD, Susan O’Brien, MD, Francis Giles, MD, Sherry Pierce, RN, BSN, BA, Jianqin Shan, PhD, William Plunkett, MD, PhD, Michael Keating, MD, Elihu Estey, MD
Journal: Blood
Blood (2005) 106 (11): 2529.
https://doi.org/10.1182/blood.V106.11.2529.2529
Published: 2005
Journal Articles

Results of Intensive Chemotherapy in 998 Patients Aged 65 Years or Older with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome - Predictive Prognostic Models for Outcome.

Elias Jabbour, MD, Hagop Kantarjian, MD, Susan O’Brien, MD, Jorge Cortes, MD, Francis Giles, MD, Stefan Faderl, MD, Guillermo Garcia-Manero, MD, William Wierda, MD, PhD, Sherry Pierce, RN, BSN, BA, Jianqin Shan, PhD, Elihu Estey, MD
Journal: Blood
Blood (2005) 106 (11): 1846.
https://doi.org/10.1182/blood.V106.11.1846.1846
Published: 2005
Journal Articles

Intracranial Hemorrhage (ICH) in Patients (pts) with Newly Diagnosed Leukemia: Incidence and Effect on Outcome.

Yasuhiro Oki, M.D., Elias Jabbour, M.D., Hagop Kantarjian, M.D., Elihu Estey, M.D., Jorge E. Cortes, M.D., Stefan Faderl, M.D., Sherry Pierce, RN, BSN, BA, Xian Zhou, MS, BS, B. Nebiyou Bekele, Ph.D., Guillermo Garcia-Manero, M.D.
Journal: Blood
Blood (2004) 104 (11): 4530.
https://doi.org/10.1182/blood.V104.11.4530.4530
Published: 2004